Adma Biologics | ADMA - Selling And Administration Expenses

Stock Price
16.32
Daily Change
0.22 1.37%
Monthly
-3.77%
Yearly
5.15%
Q1 Forecast
15.60

Adma Biologics reported $23.05M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Adma Biologics USD 23.05M 320K Sep/2025
Alnylam Pharmaceuticals USD 285.06M 22.47M Dec/2025
BioCryst Pharmaceuticals USD 80.47M 15.39M Dec/2024
Minerva Neurosciences USD 2.48M 58.79K Sep/2024
Novavax USD 66.95M 34.05M Sep/2024
Omeros USD 11.32M 2.48M Sep/2024
Takeda JPY 282.78B 29.23B Dec/2025